Ocular Inflammation in Solid Organ Transplant Patients Receiving Maintenance Immunosuppression
PURPOSE: Patients are maintained on lifelong immunomodulatory therapy (IMT) after organ transplantation; however, new inflammatory conditions have developed in transplant recipients despite systemic immunosuppression. A prior study reported uveitis in transplant patients on IMT but did not describe clinical courses. We report the first case series describing nine cases of presumed non-infectious uveitis/scleritis in transplant recipients on IMT. METHODS: Patients with a history of a solid organ transplantation who were diagnosed with uveitis and/or scleritis from June 2014 to June 2026 were identified. Inclusion required transplantation prior to uveitis/scleritis occurrence and ongoing IMT. Cases with a history of uveitis/scleritis prior to transplant, trauma/surgery, infection, or a history of autoimmune conditions causing uveitis were excluded. Nine cases met the criteria, and clinical characteristics-including transplant history and ocular disease course-were abstracted. RESULTS: = 2) transplants, were included. The mean age was 46.9 years; patients developed uveitis or scleritis a median of 4 years after the most recent transplant. All patients were treated with topical or oral corticosteroids at a minimum. Six patients had a single episode of ocular inflammation, and three patients had recurrences. All episodes were corticosteroid responsive. CONCLUSION: This case series describes presumed non-infectious ocular inflammation in solid organ transplant recipients receiving IMT, supporting a possibility of a broader pattern of post-transplant immune dysregulation. While patients in this series had steroid-responsive ocular inflammation, this phenomenon warrants further investigation to clarify mechanisms underlying new inflammation despite systemic immunosuppression, particularly because IMT agents are often employed in treating chronic uveitis.
Authors
- Kavya P. Katragadda (ORCID: https://orcid.org/0000-0001-9079-4518)
- Alan Gary Palestine (ORCID: https://orcid.org/0000-0001-6361-6767)
- Amit K. Reddy (ORCID: https://orcid.org/0000-0002-5097-823X)
- Jessica A. Kraker (ORCID: https://orcid.org/0000-0003-3376-0551)
- Lynn Marisa Hassman (ORCID: https://orcid.org/0000-0001-9939-9071)
Institutions
- University of Colorado Anschutz Medical Campus (US)
Publication Details
- Journal
- Ocular Immunology and Inflammation
- Published
- 2026-11-12
- DOI
- https://doi.org/10.1080/09273948.2026.2751588
- Primary Topic
- Ocular Diseases and Behçet’s Syndrome
- Type
- article
- Field-Weighted Citation Impact
- 0.00